🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and tolerability of TMC64...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01202825
The primary objective of the study is to evaluate the safety, tolerability,...
Status
Completed
Location
West Coast Clinical Trials, LLC
Start Date
2012-11-06
Trial ID
NCT01740791
Treatments Being Tested
The purpose of this study is to determine whether NK012 is safe and effecti...
Status
Completed
Location
Sarah Cannon Research Institute
Start Date
2007-03
Trial ID
NCT00542958
Treatments Being Tested
Background: Drug resistant tuberculosis is a serious public health problem...
Status
Unknown
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02776150
The purpose of this study is to determine the safety, efficacy and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00703118
Treatments Being Tested
This study aimed to explore the influence of organic anion transporting pol...
Status
Completed
Location
Clinical Trials Center, Seoul National University Hospital
Start Date
2010-10
Trial ID
NCT01218347
Treatments Being Tested
The effects of treatment with different doses of PEGASYS in combination wit...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT00077649
Standard therapy for chronic hepatitis C virus (HCV) is (Peg/RBV) combinati...
Status
Unknown
Location
Liver clinic
Start Date
2011-08
Trial ID
NCT01146626
Treatments Being Tested
Introduction: Several studies have evaluated and confirmed the ergogenic ef...
Status
Completed
Location
Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá
Start Date
2024-04-01
Trial ID
NCT06610110
Bearers of the sickle cell allele (S) are currently eligible for blood dona...
Status
Completed
Location
CHU Brugmann
Start Date
2018-02-13
Trial ID
NCT03405688
Treatments Being Tested